Pulmonx Corp (LUNG) USD0.001

Sell:$6.83Buy:$6.84$0.11 (1.65%)

NASDAQ:0.36%
Market closed | Prices delayed by at least 15 minutes
Sell:$6.83
Buy:$6.84
Change:$0.11 (1.65%)
Market closed | Prices delayed by at least 15 minutes
Sell:$6.83
Buy:$6.84
Change:$0.11 (1.65%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.

Key people

Steven S. Williamson
President, Chief Executive Officer, Director
Mehul Joshi
Chief Financial Officer, Principal Financial and Chief Accounting Officer
David A. Lehman
General Counsel
Geoffrey Beran Rose
Chief Commercial Officer
Dana G. Mead
Independent Chairman of Board
Glendon E. French
Director
Thomas William Burns
Independent Director
Richard M. Ferrari
Independent Director
Daniel P. Florin
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US7458481014
  • Market cap
    $263.78m
  • Employees
    279
  • Shares in issue
    39.49m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.